Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06193304 · ClinicalTrials.gov registry record · Phase 1
A Study to Evaluate Pharmacokinetic Parameters and Safety of Eliglustat Absorption Through the Mouth
A Phase 1 study, sponsored by Sanofi.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT06193304 is a Phase 1 study that has completed, run by Sanofi. The registered enrollment target is 6 participants.
The verdict
NCT06193304, a Phase 1 study, has completed, sponsored by Sanofi.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
A study to assess the absorption of eliglustat through the mouth in healthy subjects and the safety of any systemic exposure resulting from oral surface absorption of eliglustat in healthy subjects.
Interventions
- DRUG Eliglustat
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2014-08-25 |
| Est. Completion | 2014-09-21 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06193304
The ClinicalTrials.gov registry entry for NCT06193304 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanofi, which has 713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Eliglustat is the first listed.
NCT06193304 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06193304 about?
NCT06193304 is a clinical study titled "A Study to Evaluate Pharmacokinetic Parameters and Safety of Eliglustat Absorption Through the Mouth". A study to assess the absorption of eliglustat through the mouth in healthy subjects and the safety of any systemic exposure resulting from oral surface absorption of eliglustat in healthy subjects.
What is the current status of trial NCT06193304?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2014-08-25. Estimated completion is 2014-09-21.
What interventions are being tested in trial NCT06193304?
The interventions under investigation include: Eliglustat (DRUG).
Who is sponsoring clinical trial NCT06193304?
This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.